Volume : 13, Issue : 04, April – 2026
Title:
THE ROLE OF THE CLINICAL PHARMACIST IN PEDIATRIC CARE: A COMPREHENSIVE REVIEW
Authors :
Jinipe Rithika, Ramavath Manjula, Aerva Swetha, Dr. P. Soma shekhar
Abstract :
Pediatric care undoubtedly represents one of the most complex and sophisticated fields in modern-day clinical pharmacy practice.[1,25] Being a young patient implies numerous physiological and pharmacological differences which can have a significant impact on proper drug choice, dosage, and form.[3,4] Clinical pharmacists working with pediatric teams are patient safety experts who are involved at every stage of the medicines use process from dose selection and management to therapy monitoring and adverse effects identification.[1,12] The present paper gives a concise overview of current scientific evidence to highlight the important aspects of the clinical pharmacist’s work within pediatric departments including roles and responsibilities, problems associated with pediatric pharmacology, and the positive influence of pharmacists’ work on treatment results. It should be noted that scientific data proves that providing clinical pharmacist services to pediatric patients significantly decreases the number of medication-related mistakes, lowers hospitalization periods, promotes rational use of antibiotics, and positively affects the satisfaction of patients’ families.[1,6,7] Thus, enhancing pharmacists’ work in pediatric health care is crucial for further improvement of medicines use in this field.[18,21]
Keywords: clinical pharmacist, pediatric pharmacy, medication safety, pharmacokinetics in children, antimicrobial stewardship, therapeutic drug monitoring, neonatal pharmacy, multidisciplinary care
Cite This Article:
Please cite this article in press Jinipe Rithika et al., The Role Of The Clinical Pharmacist In Pediatric Care: A Comprehensive Review, Indo Am. J. P. Sci, 2026; 13(04).
REFERENCES:
1. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001;285(16):2114–2120.
2. Conroy S, McIntyre J, Choonara I. Unlicensed and off-label drug use in neonates. Arch Dis Child Fetal Neonatal Ed. 1999;80(2):F142–F145.
3. Fernandez E, Perez R, Hernandez A, et al. Factors and mechanisms for pharmacokinetic differences between pediatric population and adults. Pharmaceutics. 2011;3(1):53–72.
4. Allegaert K, van den Anker JN. Clinical pharmacology in neonates: small size, huge variability. Neonatology. 2014;105(4):344–349.
5. Stiers JL, Ward RM. Practitioner’s guide to pharmacokinetics in the pediatric patient. Pediatr Rev. 2014;35(10):424–432.
6. Cowley E, Mitchell S, Planner C, et al. Pharmacist-led interventions in the paediatric intensive care unit. Arch Dis Child. 2019;104(3):231–237.
7. Newland JG, Stach LM, De Lurgio SA, et al. Impact of a prospective-audit-with-feedback antimicrobial stewardship program at a children’s hospital. J Pediatric Infect Dis Soc. 2012;1(3):179–186.
8. Hess LM, Ewer K, Cvetkovic RS. Real-world antibiotic prescribing in pediatric infections: a global systematic review. J Pediatr Pharmacol Ther. 2010;15(2):120–132.
9. Abdel-Qader DH, Harper L, Cantrill JA, et al. Pharmacists’ interventions in prescribing errors at hospital discharge: an insight into the types of errors and pharmacist role. Eur J Intern Med. 2010;21(6):523–526.
10. Le J, Nguyen T, Law AV, et al. Adverse drug reactions among children over a 10-year period. Pediatrics. 2006;118(2):555–562.
11. Bourgeois FT, Mandl KD, Valim C, et al. Pediatric adverse drug events in the outpatient setting: an 11-year national analysis. Pediatrics. 2009;124(4):e744–e750.
12. Nkansah N, Mostovetsky O, Yu C, et al. Effect of outpatient pharmacists’ non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev. 2010;(7):CD000336.
13. Weiss SL, Fitzgerald JC, Maffei FA, et al. Discordant identification of pediatric severe sepsis by research and clinical definitions in the SPROUT international point prevalence study. Crit Care. 2015;19(1):325.
14. Pediatric Pharmacy Association. Board Certified Pediatric Pharmacy Specialist (BCPPS) examination. PPA website. Accessed 2024. Available at: https://www.ppag.org.
15. Tamma PD, Avdic E, Li DX, et al. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med. 2017;177(9):1308–1315.
16. American Society of Health-System Pharmacists. ASHP statement on the pharmacist’s role in clinical pharmacokinetic monitoring. Am J Health Syst Pharm. 1998;55(16):1726–1727.
17. Turner S, Nunn AJ, Fielding K, et al. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr. 1999;88(9):965–968.
18. World Health Organization. Promoting Safety of Medicines for Children. Geneva: WHO; 2007.
19. Cuzzolin L, Atzei A, Fanos V. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf. 2006;5(5):703–718.
20. van den Anker JN, Schwab M, Kearns GL. Developmental pharmacokinetics. Handb Exp Pharmacol. 2011;205:51–75.
21. Society of Hospital Pharmacists of Australia (SHPA). Standards of practice for clinical pharmacy. SHPA; 2020.
22. Sammons HM, Choonara I. Lessons to be learned from adverse drug reactions in the under-5s. Arch Dis Child. 2014;99(11):1037–1039.
23. Lexi-Comp Online, Pediatric Lexi-Drugs. Hudson, OH: Lexicomp; 2023.
24. Bhatt-Mehta V, Mullen EJ, Dahlem P. New perspectives in pediatric dosing. Pediatr Clin North Am. 2017;64(6):1387–1398.
25. Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology — drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349(12):1157–1167.